Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayMar 28, 2025 11:44 am

NetworkNewsBreaks – Zacks Maintains $35.00 Price Per Share Valuation for Soligenix Inc. (NASDAQ: SNGX) Amid Promising Vaccine and CTCL Therapy Progress 

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a recent Zacks Small-Cap Research report that presented a favorable analysis, emphasizing the company's advancements in vaccine and photodynamic therapy technologies.  The study highlights promising preclinical data for CiVax(TM), a thermostabilized COVID-19 booster, which demonstrated broad immune protection in non-human primates. Zacks also notes the continued progress of HyBryte(TM), Soligenix’s lead candidate for cutaneous T-cell lymphoma (“CTCL”), now in a second confirmatory Phase 3 trial, following successful results in its first Phase 3 study. Based on its discounted cash flow model that takes into account potential future…

Continue Reading

FridayMar 28, 2025 9:45 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Announces $3.9 Million Registered Direct Offering and Private Placement 

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company advancing targeted immunotherapies, has entered into a securities purchase agreement with a single institutional investor for a registered direct offering of 3,325,000 shares of common stock at $0.65 per share, or pre-funded warrants in lieu of stock. Concurrently, the company will issue series G warrants to purchase up to 6,053,000 shares of common stock in a private placement. The total gross proceeds from both transactions are expected to be approximately $3.9 million before fees and expenses. Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent. Calidi plans to…

Continue Reading

ThursdayMar 27, 2025 12:35 pm

NetworkNewsBreaks – TransCode Therapeutics Inc. (NASDAQ: RNAZ) Secures $10M in Registered Direct Offering

TransCode (NASDAQ: RNAZ), the oncology company committed to utilizing RNA therapeutics to more effectively treat cancer, has announced the closing of its sale of 10,250,000 shares of its common stock and warrants to purchase up to 10,250,000 shares of common stock priced at-the-market under Nasdaq rules, at a purchase price of $0.98 per share and accompanying warrant. The company secured approximately $10 million in gross proceeds from the offering. TransCode intends to use the proceeds primarily for product development activities, including one or more clinical trials with its lead therapeutic candidate, TTX-MC138, including related IND-enabling studies, as well as for…

Continue Reading

ThursdayMar 27, 2025 12:26 pm

NetworkNewsBreaks – CISO Global Inc.’s (NASDAQ: CISO) Achieves Profitability Milestone as Software-Led Strategy Takes Hold

CISO Global (NASDAQ: CISO) announced it achieved unaudited positive Adjusted EBITDA in Q4 2024, marking a pivotal profitability milestone as it transitions from a cyber services company to a software-led, AI-powered cybersecurity enterprise. The company credits this progress to integrating 13 acquisitions, cutting costs through proprietary AI-driven security solutions and increasing high-margin software revenue. CISO expects at least $34 million in profitable services revenue and $5 million in software bookings for 2025, with software margins projected around 75%, supported by a robust sales pipeline and insurance partnerships.  To view the full article, visit https://www.nnw.fm/xtTeC  About CISO Global Inc.  CISO Global…

Continue Reading

ThursdayMar 27, 2025 11:30 am

NetworkNewsBreaks – Massimo Group (NASDAQ: MAMO) Posts $107.5 Million in 2024 Revenue, Eyes AI Product Expansion 

Massimo Group (NASDAQ: MAMO), reported $107.5 million in revenue for fiscal 2024, up 4% from the previous year, driven by expanded UTV, ATV and e-bike sales through large U.S. retailers. The company ended the year with $19.2 million in working capital and a $9.4 million boost in cash. Operational highlights included relocating golf cart production to its Garland, Texas facility, launching a robotic assembly line and enhancing its national distribution network. Looking ahead, Massimo plans to enter the AI space by distributing robotic companions and utility assistants, broadening its reach beyond traditional powersports.  To view the full press release, visit https://nnw.fm/ESDDV …

Continue Reading

ThursdayMar 27, 2025 11:10 am

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Launches Investor Roadshow Highlighting Global Expansion Strategy

Brera Holdings (NASDAQ: BREA), an Ireland-based international sports club operator, has kicked off an investor roadshow in South Florida, with Executive Chairman Daniel McClory and CEO Pierre Galoppi presenting the company’s multi-club ownership ("MCO") strategy and recent growth developments. The sessions, taking place in West Palm Beach and Boca Raton, will showcase Brera’s expansion in both men’s and women’s football and its ongoing pursuit of new acquisitions in emerging markets. The roadshow follows recent momentum in global partnerships and portfolio growth aimed at driving long-term shareholder value.  To view the full press release, visit https://nnw.fm/s2UBp  About Brera Holdings PLC  Brera…

Continue Reading

ThursdayMar 27, 2025 10:52 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Posts Record Revenue, Plans Cost Cuts and Staff Reductions

Mullen Automotive (NASDAQ: MULN) reported record GAAP revenue of $3.18 million for the quarter ending March 31, 2025, as the electric vehicle maker intensifies its focus on cost reduction and commercial sales growth. The company will implement further staff reductions, lease eliminations and operational consolidations starting in April. Mullen is also prioritizing advancements in its battery cell and pack technologies while continuing to sell its Class 1 Mullen ONE cargo van and Class 3 Mullen THREE cab chassis truck, both fully certified for U.S. and California emissions standards. Deliveries of Bollinger’s Class 4 B4 Chassis Cab began in October.  To…

Continue Reading

ThursdayMar 27, 2025 10:30 am

NetworkNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) Finalizes Wiz Acquisition in $23 Billion Cybersecurity Push 

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) has officially agreed to acquire Israeli cloud security firm Wiz for $23 billion, reinforcing Google Cloud’s efforts to compete with Amazon and Microsoft in the cybersecurity space. The acquisition—the largest in Google’s history—signals a bold commitment to bolstering its enterprise cloud offering and capturing more market share through advanced security capabilities. Analysts see the move as a strategic win, given Wiz’s rapid growth and strong customer base, and some consider the stock a potential buy as Alphabet continues expanding into high-growth verticals.  As of mid-day trading on March 26, 2025, Alphabet shares are trading at…

Continue Reading

ThursdayMar 27, 2025 10:23 am

NetworkNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Taps AI to Speed App Development and Cut Costs

Thumzup (NASDAQ: TZUP) a rising player in social media branding and programmatic marketing, has integrated artificial intelligence tools including GitHub Copilot and Claude AI by Anthropic into its software development process. The move aims to accelerate feature rollouts for the Thumzup app, which rewards users for promoting brands they enjoy. CEO Robert Steele said the tools are already driving faster development and reducing costs, positioning Thumzup to stay competitive while offering a cutting-edge user experience. The shift aligns with broader tech startup trends, as companies increasingly rely on AI to drive rapid growth with leaner teams.  To view the full…

Continue Reading

ThursdayMar 27, 2025 10:00 am

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Option Agreement to Acquire Italian Biotech Pincell

Scinai Immunotherapeutics (NASDAQ: SCNI), announced it has signed a binding option agreement to acquire Pincell srl, an Italian biotech developing PC111, a first-in-class antibody targeting severe skin blistering disorders. In tandem, Scinai's Polish subsidiary submitted a €12 million non-dilutive grant application under the EU’s FENG program to fund the next development phase of PC111. The agreement positions Scinai to advance treatments for high-mortality conditions like pemphigus and Stevens-Johnson Syndrome without immunosuppression, with Pincell's leadership expected to integrate into Scinai’s expanding European operations. To view the full press release, visit https://nnw.fm/RlLeU About Scinai Immunotherapeutics Ltd. Scinai is a biopharmaceutical company with…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000